Stempoint Capital »

Biodesix shares owned by Stempoint Capital

Quarter-by-quarter ownership of Biodesix (BDSX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Biodesix

Tip: Access up to 7 years of quarterly data

All positions including Biodesix held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodesix by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 70k 14.50

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Praxis Precision Medicines I Com New (PRAX)
Surrozen Com New (SRZN)
Mbx Biosciences (MBX)
Mbx Biosciences (MBX)
Mineralys Therapeutics (MLYS)
Mineralys Therapeutics (MLYS)
Enliven Therapeutics (ELVN)
Enliven Therapeutics (ELVN)
Cg Oncology (CGON)
Cg Oncology (CGON)
Biohaven (BHVN)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Biodesix

AIGH Capital Management
Telemark Asset Management
Standard Life Aberdeen
Soleus Capital Management
Vanguard Capital Management
Opaleye Management
Marshall Wace
Essex Investment Management
Stempoint Capital
Trexquant Investment
Geode Capital Management
Two Sigma Investments
Perkins Capital Management
Sei Investments
Legato Capital Management

View all funds holding Biodesix